SEC Form 4 · accession 0001645627-17-000026
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Mar 31, 2017
Accepted (ET)
Apr 3, 2017 · 3:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 31, 2017 | P | 2,000 | $0.054 | A | 19,996,349 | D | |
| Common Stock | Mar 31, 2017 | P | 2,000 | $0.054 | A | 19,998,349 | D | |
| Common Stock | Mar 31, 2017 | P | 2,000 | $0.054 | A | 20,000,349 | D | |
| Common Stock | Mar 31, 2017 | P | 2,000 | $0.053 | A | 20,002,349 | D | |
| Common Stock | Mar 31, 2017 | P | 2,000 | $0.053 | A | 20,004,349 | D | |
| Common Stock | Mar 31, 2017 | P | 1,000 | $0.053 | A | 20,005,349 | D | |
| Common Stock | Mar 31, 2017 | P | 1,000 | $0.053 | A | 20,006,349 | D | |
| Common Stock | Mar 31, 2017 | P | 2,000 | $0.053 | A | 20,008,349 | D | |
| Common Stock | Apr 3, 2017 | P | 2,000 | $0.077 | A | 20,010,349 | D | |
| Common Stock | Apr 3, 2017 | P | 2,000 | $0.0768 | A | 20,012,349 | D |
Table II — derivative securities
No Table II lines on this filing.